ArticleJournal of surgical case reports2025
Beyond the weight loss: revisiting small bowel obstruction as an underestimated risk of intragastric balloons.
Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intragastric balloons (IGB) are a minimally invasive, reversible method for weight reduction in obese patients who fail conservative therapy but do not qualify for bariatric surgery. Despite their safety profile, rare yet severe complications can occur, such as small bowel obstruction (SBO) due to balloon migration. We present a case of a 37-year-old woman who developed SBO one year after gastric balloon placement, following successful weight loss. Imaging revealed a migrated balloon obstructing the jejunum, which required surgical extraction via enterotomy. This report compares our case with previously documented events, highlighting the clinical presentation, diagnostic challenges, and therapeutic decision-making. Although reported rates of obstruction remain below 0.2%, migration may occur months after the expected balloon excretion period. Persistent vigilance is required even long after IGB therapy. A stepwise diagnostic and management algorithm is proposed to guide clinicians facing this rare but potentially life-threatening complication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.